title: Bilateral irreversible blindness in leukaemic meningitis: cause or cure?
authors.forename: Christos
authors.initials: C
authors.lastname: Tziotzios
authors.forename: George
authors.initials: G
authors.lastname: Follows
authors.forename: Nicholas
authors.initials: N
authors.lastname: Sarkies
authors.forename: Charles
authors.initials: C
authors.lastname: Crawley
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D001766:Blindness / Q000139:chemically induced*; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008581:Meningitis / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D009900:Optic Nerve / Q000473:pathology; D012160:Retina / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine